Supply Chain

On Wednesday, North Carolina Governor Pat McCrory (R) signed an application that seeks a waiver from the government to allow changes to the state's $14 billion health insurance program for the poor and disabled.

Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients.

Hudson, Wis.-based injection molder Phillips-Medisize will expand its drug delivery operations with the acquisition of Medicom Innovation Partner, the companies announced on June 1st.

With drug prices on the rise, more and more drugs will be deemed ineligible for reimbursement, challenging drug developers to provide evidence of clinical superiority.

India-based drug manufacturer Aurobindo Pharma plans to focus on increased Abbreviated New Drug Application filings and new differentiated product launches in the United States to maintain its growth.

Massachusetts' Democratic lawmakers will vote on a bill to hold pharmaceutical companies more accountable for their pricing information.

The FDA recently issued a final guidance addressing post-market surveillance for medical devices, according to The National Law Review.

The medical technology company Medtronic reported better-than-expected finances last quarter due to a rise in sales for its pacemakers, stents and other medical products.

On May 27, the U.S. Food and Drug Administration granted accelerated approval to a new treatment for primary biliary cholangitis — a chronic liver disease that causes bile ducts in the liver to become inflamed, which can damage cells overtime…

A recent blog post in the reSOURCEs section of the HealthTrust public website discusses how the new UDI system will affect healthcare operations.